Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology Annual Meeting Life Science Investing
Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology Annual Meeting Life Science Investing
Immix Biopharma's NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025 Biotech Investing
PharmAla Files Final Base Shelf Prospectus and Signs Term Sheet with Radium Capital Life Science Investing
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in London Life Science Investing
ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results Life Science Investing
Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging Life Science Investing
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology Annual Scientific Meeting Life Science Investing
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology Kidney Week 2025 Life Science Investing
Benitec Biopharma Provides Positive Interim Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial and Receives FDA Fast Track Designation for BB-301 Life Science Investing
